| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 666.2 | 721.5 | 558.8 |
| Other income | 15.2 | 4.2 | 9.0 |
| Total income | 681.4 | 725.7 | 567.8 |
| Profit before exceptional items & tax | 113.4 | 129.7 | 81.2 |
| Profit before tax | 113.4 | 129.7 | 81.2 |
| Net profit | 82.8 | 94.1 | 57.6 |
| Operating margin | 16.6% | 17.9% | 14.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +43.70% |
|---|---|
| Net profit, quarter on quarter | -12.00% |
| Revenue, year on year | +19.20% |
| Operating profit, year on year | +39.10% |
| Operating profit, quarter on quarter | -24.80% |
NSE results filing, NSE: PRIVISCL. Figures extracted from the filing.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,504.90
- Market cap
- ₹13,691 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 39.1×Sector 37.2×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Annual General Meeting
Privi Speciality Chemicals Ltd held its 41st Annual General Meeting on August 7, 2026. The meeting covered financial adoption, dividend declaration, and director appointments.
Privi Speciality Chemicals Earnings Call Transcript: Key Takeaways
Privi reports 19.22% revenue growth and steady 24% EBITDA margins. Management maintains a confident outlook on expansion despite gross margin compression from high raw material costs compared to last year's low-cost base.
- Call
- Guides 100% growth
Privi Speciality Chemicals Investor Presentation: Key Takeaways
Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.
- Call
- Guides 100% growth
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.